Development, Optimization and Evaluation of 2-Methoxy-Estradiol Loaded Nanocarrier for Prostate Cancer

The therapeutic efficacy of antineoplastic agents possessing a selective target to the nucleus of the cancer cells could be enhanced through novel formulation approaches. Thus, toward the improvement of the anticancer potential of 2-methoxy estradiol (2 ME) on prostate cancer, the drug was entrapped...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhakamy, Nabil A., Ahmed, Osama A., Fahmy, Usama A., Asfour, Hani Z., Alghaith, Adel F., Mahdi, Wael A., Alshehri, Sultan, Md, Shadab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322574/
https://www.ncbi.nlm.nih.gov/pubmed/34335251
http://dx.doi.org/10.3389/fphar.2021.682337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322574/
https://www.ncbi.nlm.nih.gov/pubmed/34335251
http://dx.doi.org/10.3389/fphar.2021.682337

Ejemplares similares